Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P.A. Gehrig
Simvastatin, an HMG-CoA Reductase Inhibitor, Exhibits Antimetastatic and Antitumorigenic Effects in Endometrial Cancer
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
Related publications
Simvastatin, an HMG-CoA Reductase Inhibitor, Exhibits Anti-Metastatic and Anti-Tumorigenic Effects in Endometrial Cancer
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
Pitavastatin, an HMG-CoA Reductase Inhibitor, Ameliorates Endothelial Function in Chronic Smokers
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
Effects of an HMG-CoA Reductase Inhibitor on Cytokine Production by Human Monocytes/Macrophages.
Journal of Nippon Medical School
Characterization of an HMG-CoA Reductase From Listeria Monocytogenes That Exhibits Dual Coenzyme Specificity
Effects of Combined Therapy Using HMG-CoA Reductase Inhibitor and Colestimide on Refractory Hypercholesterolemia
The Journal of Japan Atherosclerosis Society
Pleiotropic Effects of the HMG-CoA Reductase Inhibitors
International Journal of General Medicine
Medicine
HMG-CoA Reductase Inhibitor Simvastatin Mitigates VEGF-induced "Inside-Out" Signaling to Extracellular Matrix by Preventing RhoA Activation
AJP: Renal Physiology
Fluvastatin, an HMG-CoA Reductase Inhibitor, Protects LDL From Oxidative Modification in Hypercholesterolemic Rabbits.
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Mechanism of HMG-CoA Reductase Inhibitor-Induced Contractile Dysfunction in Rat Cultured Skeletal Muscle
Biophysical Journal
Biophysics